Patent · US Active

PGDH inhibitors and methods of making and using

US11891389B2 · kind B2 · utility

0Cited by

1References

20Claims

0Family size

Assignee

Myoforte Therapeutics, Inc. · US

Inventors

Roopa Rai · San Carlos, US
Robert Booth · Los Altos Hills, US
Michael J. Green · Skillman, US

Key dates

Filing date	Apr 20, 2022
Grant date	Feb 6, 2024
Priority date	—
Expiry date	Jul 8, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are compounds that can inhibit 15-hydroxyprostaglandin dehydrogenase. Such compounds may be administered to subjects that may benefit from modulation of prostaglandin levels.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.